Inflammation in overuse tendon injuries

Sports Medicine and Arthroscopy Review

Volumn 19, Issue 3, 2011, Pages 213-217

  Battery, Lucy ^a   Maffulli, Nicola ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

chronic inflammatory state; decreased insulin sensitivity; failed healing response; future management; obesity; risk factors; tendinopathy

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

DISEASE COURSE; DISEASE PREDISPOSITION; HEALING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TENDINITIS;

CUMULATIVE TRAUMA DISORDERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; SEVERITY OF ILLNESS INDEX; TENDINOPATHY; TENDON INJURIES;

EID: 80051753227     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0b013e31820e6a92     Document Type: Review

References (37)

1. Abate M, Gravare Silbernagel K, Siljeholm C, et al. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther. 2009;11:235.
2. Cook J, Purdam C. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43:409.
3. Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med. 2009;37:1855-1867.
4. Maffulli N, Longo UG, Loppini M, et al. Current treatment options for tendinopathy. Expert Opin Pharmacother. 2010;11:2177-2186.
5. Longo UG, Ronga M, Maffulli N. Achilles tendinopathy. Sports Med Arthrosc. 2009;17:112-126.
6. Maffulli N, Longo UG, Maffulli GD, et al. Marked pathological changes proximal and distal to the site of rupture in acute Achilles tendon ruptures. Knee Surg Sports Traumatol Arthrosc. 2010. Epub ahead of print: DOI: 10.1007/s00167-010-1193-2.
7. Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010;92:2604-2613.
8. Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature. Med Sci Sports Exerc. 1998;30:1183-1190. (Pubitemid 28369220)
9. Abate M. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther. 2009;11:235.
10. Ramchurn N, Mashamba C, Leitch E, et al. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20:4.
11. Hirai S, Takahashi N, Goto T, et al. Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediators Inflamm. 2010;2010:367838.
12. Gaida J, Ashe M, Bass S, et al. Is adiposity an under-recognized risk factor for tendinopathy? A systematic review. Arthritis Rheum. 2009;61:840.
13. Roth CL, Kratz M, Ralston MM, et al. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism. 2010.
14. Matarese G, Procaccini C, De Rosa V, et al. Regulatory T cells in obesity: the leptin connection. Trends Mol Med. 2010;6:247-256.
15. Wendelboe AM, Hegmann KT, Gren LH, et al. Associations between body-mass index and surgery for rotator cuff tendinitis. J Bone Joint Surg Am. 2004;86-A:743.
16. Wenner M. Inflammatory clues. Scientific American. 2009;301:24-26.
17. Freeman JS. A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12 suppl):S5-S14.
18. Lewis JS, Sandford FM. Rotator cuff tendinopathy: is there a role for polyunsaturated Fatty acids and antioxidants? J Hand Ther. 2010;22:49.
19. Karousou E, Ronga M, Vigetti D, et al. Molecular interactions in extracellular matrix of tendon. Front Biosci (Elite Ed). 2010;2:1-12.
20. Millar NL, Hueber AJ, Reilly JH, et al. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010;38:2085-2091.
21. Mavrikakis M, Drimis S, Kontoyannis DA, et al. Calcific shoulder periarthritis (tendinitis) in adult onset diabetes mellitus: a controlled study. Ann Rheum Dis. 1989;48:211.
22. Scott A, Lian Ø, Bahr R, et al. Increased mast cell numbers in human patellar tendinosis: correlation with symptom duration and vascular hyperplasia. Br J Sports Med. 2008;42:753.
23. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003.
24. Avvedimento EV, Gabrielli A. Stiff and tight skin: a rear window into fibrosis without inflammation. Sci Transl Med. 2010;2:13.
25. Raatikainen T, Karpakka J, Puranen J, et al. Operative treatment of partial rupture of the patellar ligament-a study of 138 cases. Int J Sports Med. 1994;15:46-49. (Pubitemid 24051866)
26. Potter H, Hannafin J, Morwessel R, et al. Lateral epicondylitiscorrelation of MR-imaging, surgical, and histopathologic findings. Radiology. 1995;196:43-46.
27. Sullo A, Maffulli N, Capasso G, et al. The effects of prolonged peritendinous administration of PGE1 to the rat Achilles tendon: a possible animal model of chronic Achilles tendinopathy. J Orthop Sci. 2001;6:349.
28. Cilli F, Khan M, Fu F, et al. Prostaglandin E∼2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin J Sports Med. 2004;14:232-236. (Pubitemid 38989680)
29. Khan K, Maffulli N. Tendinopathy: an achilles' heel for athletes and clinicians. Clin J Sports Med. 1998;8:151-154. (Pubitemid 28457119)
30. Thampatty BP, Im H-J, Wang JH. Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts. Gene. 2006;372:103.
31. Fu SC, Wang W, Pau HM, et al. Increased expression of transforming growth factor-beta1 in patellar tendinosis. Clin Orthop Relat Res. 2002;4:174.
32. Radak Z, Takahashi R, Kumiyama A, et al. Effect of aging and late onset dietary restriction on antioxidant enzymes and proteasome activities, and protein carbonylation of rat skeletal muscle and tendon. Exp Gerontol. 2002;37:1423.
33. Longo UG, Franceschi F, Ruzzini L, et al. Higher fasting plasma glucose levels within the normoglycaemic range and rotator cuff tears. Br J Sports Med. 2009;43:284-287.
34. Gotto AM Jr. Triglyceride as a risk factor for coronary artery disease. Am J Cardiol. 1998;82:22Q-25Q. (Pubitemid 128712604)
35. Longo UG, Franceschi F, Spiezia F, et al. Triglycerides and total serum cholesterol in rotator cuff tears: do they matter? Br J Sports Med. 2010;44:948-951.
36. (NICE) NIfHaCE. Statins for the prevention of cardiovascular events: National Institute for Health and Clinical Excellence (NICE) 2008 Contract No.: T094.
37. Marie I, Delafenetre H, Massy N, et al. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum. 2008;59:367.